| Avina Kapoor Singh, MD | |
|
675 E Nicollet Blvd Ste 100, Burnsville, MN 55337-6749 | |
| (952) 892-7190 | |
| (952) 892-7956 |
| Full Name | Avina Kapoor Singh |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 25 Years |
| Location | 675 E Nicollet Blvd Ste 100, Burnsville, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821201666 | NPI | - | NPPES |
| 136D4SI | Other | MN | BLUECROSS/BLUESHIELD |
| HP79138 | Other | MN | HEALTHPARTNERS |
| 051 | Other | MN | AMERICA'S PPO |
| 34787500 | Medicaid | WI | |
| 017617000 | Medicaid | MN | |
| 1050664 | Other | MN | PREFERREDONE |
| 139266 | Other | MN | UCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 49617 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Abode Hospice And Homecare Of Mn Llc | Woodbury, MN | Hospice |
| Fairview Ridges Hospital | Burnsville, MN | Hospital |
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Fairview Southdale Hospital | Edina, MN | Hospital |
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Minnesota Oncology Hematology, Pa | 6709799752 | 104 |
News Archive
A new study produced by an interdisciplinary team led by Prof. Antonio Giordano, director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, tracks the development process and efficacy of the Italian translation of the Derriford Appearance Scale 24, an important clinical tool in identifying quality-of-life issues for breast cancer patients, especially concerns regarding body shame, depression, anxiety, overall appearance and appearance identity.
Unexpected discovery of a new molecular signature for a destructive and often lethal pediatric liver disease may lead to a new therapeutic target for the hard-to-treat condition.
Nektar Therapeutics today announced preliminary results from the first stage of a two-stage Phase 2 clinical study evaluating NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients enrolled with platinum-resistant disease were evaluable for the primary endpoint of overall response rate using Gynecologic Cancer InterGroup (GCIG) criteria, i.e., a combination of response by tumor imaging
Patients with severe congestive heart failure who had exhausted all other treatment options showed markedly improved heart function following a procedure in which their own stem cells were deployed directly into the heart by way of four tiny incisions in the chest, according to results of a trial presented today at the 41st Annual Meeting of the Society for Thoracic Surgery.
A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In laboratory tests of rectal tissue, researchers from the Microbicide Trials Network (MTN) found that the reformulated gel was less harmful to the lining of the rectum than the original vaginal formulation, and just as effective in protecting cells against HIV.
› Verified 1 days ago
| Entity Name | Minnesota Oncology Hematology, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528035995 PECOS PAC ID: 6709799752 Enrollment ID: O20031106000626 |
News Archive
A new study produced by an interdisciplinary team led by Prof. Antonio Giordano, director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, tracks the development process and efficacy of the Italian translation of the Derriford Appearance Scale 24, an important clinical tool in identifying quality-of-life issues for breast cancer patients, especially concerns regarding body shame, depression, anxiety, overall appearance and appearance identity.
Unexpected discovery of a new molecular signature for a destructive and often lethal pediatric liver disease may lead to a new therapeutic target for the hard-to-treat condition.
Nektar Therapeutics today announced preliminary results from the first stage of a two-stage Phase 2 clinical study evaluating NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients enrolled with platinum-resistant disease were evaluable for the primary endpoint of overall response rate using Gynecologic Cancer InterGroup (GCIG) criteria, i.e., a combination of response by tumor imaging
Patients with severe congestive heart failure who had exhausted all other treatment options showed markedly improved heart function following a procedure in which their own stem cells were deployed directly into the heart by way of four tiny incisions in the chest, according to results of a trial presented today at the 41st Annual Meeting of the Society for Thoracic Surgery.
A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In laboratory tests of rectal tissue, researchers from the Microbicide Trials Network (MTN) found that the reformulated gel was less harmful to the lining of the rectum than the original vaginal formulation, and just as effective in protecting cells against HIV.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Avina Kapoor Singh, MD 675 E Nicollet Blvd Ste 100, Burnsville, MN 55337-6749 Ph: (952) 892-7190 | Avina Kapoor Singh, MD 675 E Nicollet Blvd Ste 100, Burnsville, MN 55337-6749 Ph: (952) 892-7190 |
News Archive
A new study produced by an interdisciplinary team led by Prof. Antonio Giordano, director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, tracks the development process and efficacy of the Italian translation of the Derriford Appearance Scale 24, an important clinical tool in identifying quality-of-life issues for breast cancer patients, especially concerns regarding body shame, depression, anxiety, overall appearance and appearance identity.
Unexpected discovery of a new molecular signature for a destructive and often lethal pediatric liver disease may lead to a new therapeutic target for the hard-to-treat condition.
Nektar Therapeutics today announced preliminary results from the first stage of a two-stage Phase 2 clinical study evaluating NKTR-102 in women with platinum-resistant ovarian cancer. In the first stage of the study, 39 patients enrolled with platinum-resistant disease were evaluable for the primary endpoint of overall response rate using Gynecologic Cancer InterGroup (GCIG) criteria, i.e., a combination of response by tumor imaging
Patients with severe congestive heart failure who had exhausted all other treatment options showed markedly improved heart function following a procedure in which their own stem cells were deployed directly into the heart by way of four tiny incisions in the chest, according to results of a trial presented today at the 41st Annual Meeting of the Society for Thoracic Surgery.
A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In laboratory tests of rectal tissue, researchers from the Microbicide Trials Network (MTN) found that the reformulated gel was less harmful to the lining of the rectum than the original vaginal formulation, and just as effective in protecting cells against HIV.
› Verified 1 days ago
Dr. Traci Arnette Roberts, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 201 E Nicollet Blvd, Burnsville, MN 55337 Phone: 952-892-2000 | |
Daniel Bret Frechette, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 201 E Nicollet Blvd, Burnsville, MN 55337 Phone: 952-892-2000 | |
Krishnakumari G Pallegar, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 303 Nicollet Blvd, Burnsville, MN 55337 Phone: 952-892-8770 | |
Zhen Zhen Luo, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 14000 Fairview Dr, Burnsville, MN 55337 Phone: 952-993-8700 | |
Lynn Janette Koch, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 303 Nicollet Blvd, Burnsville, MN 55337 Phone: 952-892-8770 | |
Mary E Wahl, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 303 Nicollet Blvd, Burnsville, MN 55337 Phone: 952-892-8770 | |
Derek William Eklund, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 201 E Nicollet Blvd, Burnsville, MN 55337 Phone: 952-892-2436 |